Ketorolac + Lidocaine for Pain Relief During Hysteroscopy
Trial Summary
What is the purpose of this trial?
A randomized double-blind placebo controlled trial comparing the effect of a combined ketorolac and lidocaine paracervical block with a standard lidocaine paracervical block on procedure related pain with office hysteroscopies.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, if you have a history of long-term narcotic use, you may not be eligible to participate.
What data supports the effectiveness of the drug combination of Ketorolac and Lidocaine for pain relief during hysteroscopy?
Research on similar procedures, like first-trimester surgical abortion, shows that a paracervical block with combined ketorolac and lidocaine can help reduce perceived pain. Additionally, studies on other procedures suggest that combining local anesthesia with a paracervical block can improve pain relief.12345
How does the drug Ketorolac + Lidocaine for pain relief during hysteroscopy differ from other treatments?
The combination of Ketorolac and Lidocaine in a paracervical block is unique because it combines a non-steroidal anti-inflammatory drug (NSAID) with a local anesthetic, potentially offering enhanced pain relief by addressing both inflammation and nerve pain directly at the cervix, unlike other methods that may use these components separately or rely on systemic administration.12346
Research Team
Charles Ascher-Walsh, MD
Principal Investigator
Icahn School of Medicine at Mount Sinai
Eligibility Criteria
This trial is for individuals experiencing abnormal uterine bleeding who are undergoing office hysteroscopy, a procedure to look inside the uterus. Participants should meet certain health criteria not specified here.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a standard lidocaine paracervical block or a lidocaine plus ketorolac paracervical block during office hysteroscopy
Follow-up
Participants are monitored for pain, patient satisfaction, and adverse events immediately after the procedure and 30 minutes post-procedure
Long-term follow-up
Participants are followed for the duration of the two-year study period to assess long-term outcomes and adverse events
Treatment Details
Interventions
- Combined Ketorolac and Lidocaine Paracervical Block (Non-opioid Analgesic)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Icahn School of Medicine at Mount Sinai
Lead Sponsor
Dr. Brendan Carr
Icahn School of Medicine at Mount Sinai
Chief Executive Officer since 2024
MD, MA, MS
Dr. Vicki LoPachin
Icahn School of Medicine at Mount Sinai
Chief Medical Officer
MD, FACP, MBA